PBYI(Puma Biotechnology, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $253.16M | $228.03M | $235.64M | $230.47M | $228.37M |
| 毛利润 | $189.45M | $172.94M | $172.96M | $166.06M | $170.21M |
| 营业利润 | $1.29M | $23.72M | $32.64M | $30.97M | $37.30M |
| 净利润 | −$29.13M | $2.00K | $21.59M | $30.28M | $31.11M |
| 经营现金流 | $20.65M | −$15.83M | $27.01M | $38.92M | $41.80M |
| 自由现金流 | $20.65M | −$15.83M | $26.87M | $38.86M | $41.73M |
| 摊薄每股收益 | $-0.72 | $0.00 | $0.45 | $0.62 | $0.61 |